Director Arjun Desai Sells 30,000 Shares of TriSalus Life Sciences Inc (TLSI)

Author's Avatar
Dec 13, 2024

On December 10, 2024, Arjun Desai, a Director at TriSalus Life Sciences Inc (TLSI, Financial), sold 30,000 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 247,127 shares of the company. TriSalus Life Sciences Inc is a company focused on developing innovative therapies for patients with liver and pancreatic tumors. The company aims to improve the delivery of therapeutics to these challenging tumor environments, enhancing treatment efficacy and patient outcomes. The insider transaction history for TriSalus Life Sciences Inc indicates that there have been four insider buys and two insider sells over the past year. This recent sale by Arjun Desai is part of the two insider sells recorded during this period. Shares of TriSalus Life Sciences Inc were trading at $3.69 each on the day of the transaction, giving the stock a market cap of $121.059 million.

1867360431090331648.png

Over the past year, Arjun Desai has sold a total of 30,000 shares and has not purchased any shares. This activity is consistent with the overall insider trend at TriSalus Life Sciences Inc, where insider buying has been more prevalent than selling. For investors, it is important to consider various valuation metrics such as the GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow when evaluating the stock. These metrics can provide a more comprehensive view of the company's financial health and market position.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.